English
简体中文
Total: £ 56.28
2026-03-30 | Pages: 114 | Tables: 108
The global Botulinum Toxin in Medical Cosmetology market was valued at US$ 9183 million in 2025 and is anticipated to reach US$ 15840 million by 2032, at a CAGR of 8.2% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty in...
2026-03-30 | Pages: 112 | Tables: 111
The global GMP Cell Banking market was valued at US$ 794 million in 2025 and is anticipated to reach US$ 1765 million by 2032, at a CAGR of 12.3% from 2026 to 2032.Cell banking systems are set up to assure that a uniform population of cells is preser...
2026-03-27 | Pages: 112 | Tables: 117
The global Pet Skin and Coat Health Supplement market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global econ...
2026-03-27 | Pages: 110 | Tables: 115
The global Medication For Dairy Cows market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic lands...
2026-03-27 | Pages: 128 | Tables: 132
The global Oral Parkinson's Disease Medications market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global eco...
2026-03-27 | Pages: 133 | Tables: 130
The global Oral Antiparkinsonian Drugs market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic lan...
2026-03-27 | Pages: 129 | Tables: 132
The global Oral Medications for Parkinson's Disease market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global...
2026-03-27 | Pages: 115 | Tables: 116
The global Herpes Simplex Virus Treatment market was valued at US$ 1866 million in 2025 and is anticipated to reach US$ 2276 million by 2032, at a CAGR of 2.9% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the gl...
2026-03-27 | Pages: 114 | Tables: 117
The global Poly (ADP-Ribose) Polymerase (PARP) Inhibitors market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the ...
2026-03-27 | Pages: 119 | Tables: 123
The global Cathepsin Inhibitors market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape....
2026-03-27 | Pages: 129 | Tables: 136
The global Epidermal Growth Factor Receptor Inhibitors market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the glo...
2026-03-27 | Pages: 113 | Tables: 108
The global Antisense Oligonucleotides (ASOs) Drugs market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global ...
2026-03-27 | Pages: 110 | Tables: 111
The global Compound Miconazole Nitrate Cream market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global econom...
2026-03-27 | Pages: 117 | Tables: 113
The global Ointment for Hemorrhoids market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.Ointment for Hemorrhoids: This is a topical medication used to relieve symptoms associated w...
2026-03-27 | Pages: 92 | Tables: 91
The global Semaglutide Oral Drug market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape...
